Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023;25(6):143-158.
doi: 10.1007/s11936-023-00982-9. Epub 2023 Apr 21.

Coronary Revascularization in Patients With Cancer

Affiliations
Review

Coronary Revascularization in Patients With Cancer

Bala Pushparaji et al. Curr Treat Options Cardiovasc Med. 2023.

Abstract

Purpose of review: The treatment of coronary artery disease (CAD) in cancer patients is an evolving landscape. Recent data emphasizes the importance of aggressive management of cardiovascular risk factors and diseases in improving cardiovascular health in this unique group of patients regardless of cancer type or stage.

Recent findings: Novel cancer therapeutics such as immune therapies and proteasome inhibitors have been associated with CAD. Recent stent technologies may safely allow for shorter duration (< 6 months) of dual antiplatelet therapy post-percutaneous coronary interventions. Intracoronary imaging may be useful in the decision making process in terms of stent positioning and healing.

Summary: Large registry studies have partially filled a gap left by the lack of randomized controlled trials in the treatment of CAD in cancer patients. Cardio-oncology is gaining traction as a major sub-specialty in the cardiology field given the release of the first European Society of Cardiology - Cardio-oncology guidelines in 2022.

Keywords: ACS; Acute coronary syndrome; CAD; Cancer; Cardio-oncology; Coronary artery disease; Myocardial infarction; PCI; Radiation.

PubMed Disclaimer

Conflict of interest statement

Conflict of InterestBala Pushparaji declares that he has no conflict of interest. Teodora Donisan declares that she has no conflict of interest. Dinu Valentin Balanescu declares that he has no conflict of interest. Jong Kun Park declares that he has no conflict of interest. Dominique J. Monlezun declares that he has no conflict of interest. Abdelrahman Ali declares that he has no conflict of interest. Ibrahim Halil Inanc declares that he has no conflict of interest. Jaime Caballero declares that he has no conflict of interest. Mehmet Cilingiroglu declares that he has no conflict of interest. Konstantinos Marmagkiolis declares that he has no conflict of interest. Cezar Iliescu declares that he has no conflict of interest.

Figures

Fig. 1
Fig. 1
Recent updates in coronary revascularization in cancer patients. ICI, immune checkpoint inhibitors; ACS, acute coronary syndrome; TTE, transthoracic echocardiogram; STEMI, ST segment elevation myocardial infarction; NSTEMI, non-ST segment elevation myocardial infarction; DAPT, dual antiplatelet therapy; FFR, fractional flow reserve; iFR, instantaneous wave-free ratio; IVUS, intravascular ultrasound; OCT, optical coherence tomography; SADIT, single-access, dual-injection technique; SHiP, Single access for Hi-risk PCI; TEG, thromboelastogram; PCI, percutaneous coronary intervention.

References

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: •  Of importance •• Of major importance
    1. Murphy SL, Kochanek KD, Xu JA, Arias E, National Center for Health Statistics (U.S.). Division of vital statistics. Mortality in the United States, 2020. Published Date: 12/22/2021. Series: NCHS data brief no. 427. URL: https://stacks.cdc.gov/view/cdc/112079 - PubMed
    1. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117–71. - PMC - PubMed
    1. Koene RJ, et al. Shared risk factors in cardiovascular disease and cancer. Circulation. 2016;133(11):1104–1114. doi: 10.1161/CIRCULATIONAHA.115.020406. - DOI - PMC - PubMed
    1. Giza DE, et al. Cancer as a risk factor for cardiovascular disease. Curr Oncol Rep. 2017;19(6):39. doi: 10.1007/s11912-017-0601-x. - DOI - PubMed
    1. Amsterdam EA, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014;64(24):e139–e228. doi: 10.1016/j.jacc.2014.09.017. - DOI - PubMed